Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study

SARS-CoV-2 is the pathogen agent of the new corona virus disease that appeared at the end of 2019 in China. There is, currently, no effective treatment against COVID-19. We report in this study a molecular docking study of ten Aloe vera molecules with the main protease (3CLpro) responsible for the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mpiana, Pius T., Ngbolua, Koto-te-Nyiwa, Tshibangu, Damien S.T., Kilembe, Jason T., Gbolo, Benjamin Z., Mwanangombo, Domaine T., Inkoto, Clement L., Lengbiye, Emmanuel M., Mbadiko, Clement M., Matondo, Aristote, Bongo, Gedeon N., Tshilanda, Dorothée D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833182/
https://www.ncbi.nlm.nih.gov/pubmed/33518775
http://dx.doi.org/10.1016/j.cplett.2020.137751

Ejemplares similares

Ejemplares similares